Pharmacokinetics and toxicity of ciprofloxacin in adult horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 33, Issue 6, 2010, Pages 587-594

  Yamarik, T A ^a   Wilson, W D ^a   Wiebe, V J ^a,b   Pusterla, N ^a   Edman, J ^a   Papich, M G ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

AGITATION; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; COLITIS; DIARRHEA; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; EDEMA; ENDOTOXEMIA; EXCITEMENT; FASCICULATION; FEMALE; HORSE; LETHARGY; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; COLITIS; ENDOTOXEMIA; FEMALE; HALF-LIFE; HORSE DISEASES; HORSES; INJECTIONS, INTRAVENOUS; MALE;

EQUIDAE;

EID: 78349296061     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2010.01167.x     Document Type: Article

References (38)

1. Asuquo, A.E. & Piddock, L.J. (1993) Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 31, 865-880.
2. Bermingham, E.C. & Papich, M.G. (2002) Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. American Journal Veterinary Research, 63, 1012-1017.
3. Bermingham, E.C., Papich, M.G. & Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706-709.
4. Bertone, A.L., Tremaine, W.H., Macoris, D.G., Simmons, E.J., Ewert, K.M., Herr, L.G. & Weisbrode, S.E. (2000) Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses. Journal of the American Veterinary Medical Association, 217, 1514-1521.
5. ® 100) in horses. Veterinary Therapeutics, 2, 129-134.
6. Bousquet-Lelou, A., Bernard, S., Schneider, M. & Toutain, P.L. (2002) Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal, 34, 366-372.
7. Clark, C., Greenwood, S., Boison, J.O., Chirino-Trejo, M. & Dowling, P.M. (2008) Bacterial isolates from equine infections in western Canada (1998-2003). The Canadian Veterinary Journal, 49, 153-160.
8. Davis, J.L., Salmon, J.H. & Papich, M.G. (2006a) Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. American Journal of Veterinary Research, 67, 310-316.
9. Davis, J.L., Papich, M.G. & Weingarten, A. (2006b) The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 191-197.
10. Dowling, P.M., Wilson, R.C., Tyler, J.W. & Duran, S.H. (1995) Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Phamracology and Therapeutics, 18, 7-12.
11. Ensink, J.M., Van Klingeren, B., Houwers, D.J., Klein, W.R. & Vulto, A.G. (1993) In vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in the Netherlands. Equine Veterinary Journal, 25, 309-313.
12. Epstein, K., Cohen, N., Boothe, D., Nieuwoudt, C & Chandler, J. (2004) Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses. Veterinary Therapeutics, 5, 155-167.
13. Gardner, S.Y., Davis, J.L., Jones, S.L., LaFevers, D.H., Hoskins, M.S., McArver, E.M. & Papich, G.M. (2004) Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics, 27, 57-60.
14. Giguère, S. & Bélanger, M. (1997) Concentration of enrofloxacin in equine tissues after long term oral administration. Journal of Veterinary Pharmacology and Therapeutics, 20, 402-404.
15. Giguère, S., Raymond, W., Sweeney, W. & Bélanger, M. (1996) Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 57, 1025-1030.
16. Giguère, S., Sweeney, R.W., Habecker, P.L., Lucas, J. & Richardson, D.W. (1999) Tolerability of orally administered enrofloxacin in adult horses: a pilot study. Journal of Veterinary Pharmacology and Therapeutics, 22, 343-347.
17. Griffiths, N.M., Hurst, B.H. & Simmons, N.L. (1994) Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? Journal of Pharmacology and Experimental Therapeutics, 269, 496-502.
18. Haines, G.R., Brown, M.P., Gronwall, R.R. & Merritt, K.A. (2000) Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Canadian Journal of Veterinary Research, 64, 171-177.
19. Langston, V.C., Sedrish, S. & Boothe, D.M. (1996) Disposition of single-dose oral enrofloxacin in the horse. Journal of Veterinary Pharmacology and Therapeutics, 19, 316-319.
20. Maitho, T.E., Lees, P. & Taylor, J.B. (1986) Absorption and pharmacokinetics of phenylbutazone in Welsh mountain ponies. Journal of Veterinary Pharmacology and Therapeutics, 9, 26-39.
21. McEvoy, G.K. (Ed.). (2008) American Hospital Formulary Service Drug Information. American Society of Health-System Pharmacists, Bethesda, MD.
22. Moore, R.M., Schneider, R.K., Kowalski, J., Bramlage, L.R., Mecklenburg, L.M. & Kohn, K.W. (1992) Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989. Equine Veterinary Journal, 24, 450-456.
23. Orsini, J.A., Benson, C.E., Spencer, P.A. & Van Miller, E.V. (1989) Resistance to gentamicin and amikacin of Gram-negative organisms isolated from horses. American Journal of Veterinary Research, 50, 923-925.
24. Papich, M.G. (2003) Antimicrobial therapy for gastrointestinal diseases. Veterinary Clinics of North America. Equine Practice, 19, 645-663.
25. Papich, M.G. & Davis, J.L. (2007) Antimicrobial therapy. In Equine Infectious Diseases. Eds Sellon, D.C. & Long, M.T., pp. 578-591. Saunders, Elsevier Inc., St Louis, MO.
26. Papich, M.G. & Riviere, J.E. (2001) Fluoroquinolone antimicrobial drug. In Veterinary Pharmacology and Therapeutics, 8th edn, ed. Adams, H.R., pp. 898-917. Iowa State University Press, Ames, IA.
27. Papich, M.G., Van Camp, S.D., Cole, J.A. & Whitacre, M.D. (2002) Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares. Journal of Veterinary Pharmacology and Therapeutics, 25, 343-350.
28. Park, S. (2002) Pharmacokinetics of ciprofloxacin after intravenous and intramuscular administration in healthy horses. The Indian Veterinary Journal, 79, 904-908.
29. Peyrou, M., Bousquet-Melou, A., Laroute, V., Vrins, A. & Doucet, M.Y. (2006) Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetics parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction. Journal of Veterinary Pharmacology and Therapeutics, 29, 337-344.
30. Pyörälä, S., Panu, S. & Kaartinen, L. (1994). Single dose pharmacokinetics of ciprofloxacin in horses. Proceedings of European Academy of Veterinary Pharmacology and Therapeutics (EAVPT), pp. 45-46 [abstract P-18].
31. Seguin, M.A., Papich, M.G., Sigle, K.J., Gibson, N.M. & Levy, J.K. (2004) Pharmacokinetics of enrofloxacin in neonatal kittens. American Journal of Veterinary Research, 65, 350-356.
32. Staempfli, H.R., Townsend, G.G. & Prescott, J.F. (1991) Prognostic features and clinical presentation of acute idiopathic enterocolitis in horses. Canadian Veterinary Journal, 32, 232-237.
33. Steinman, A., Britzi, M., Levi, O., Lavy, E., Lichter, A. & Soback, S. (2006) Lack of effect of diet on the pharmacokinetics of enrofloxacin in horses. Journal of Veterinary Pharmacology and Therapeutics, 29, 67-70.
34. Van der Harst, M.R., Bull, S., Laffont, C.M. & Klein, W.R. (2005) Gentamicin nephrotoxicity-a comparison of in vitro findings with in vivo experiments in equines. Veterinary Research Communications, 29, 247-261.
35. Van Duijkeren, E., Vulto, A.G., Sloet van Oldruitenborgh-Oosterbaan, M.M., Kessels, B.G., Van Miert, A.S. & Breukink, H.J. (1995) Pharmacokinetics of trimethoprim/sulfachlorpyridazine in horses after oral, nasogastric and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 18, 47-53.
36. Van Duijkeren, E., Kessels, B.G., Sloet van Oldruitenborgh-Oosterbaan, M.M., Breukink, H.J., Vulto, A.G. & Van Miert, A.S. (1996) In vitro and in vivo binding of trimethoprim and sulfachlorpyridazine to equine food and digesta and their stability in caecal contents. Journal of Veterinary Pharmacology and Therapeutics, 19, 281-287.
37. Van Duijkeren, E., Ensink, J.M. & Meijer, L.A. (2002) Distribution of orally administered trimethoprim and sulfadiazine into noninfected subcutaneous tissue chambers in adult ponies. Journal of Veterinary Pharmacology and Therapeutics, 25, 273-277.
38. Weese, J.S., Kaese, H.J., Baird, J.D., Kenney, D.G. & Staempfli, H.R. (2002) Suspected ciprofloxacin-induces colitis in four horses. Equine Veterinary Education, 14, 182-189.